PDPL Intraday Analysis...

PDPL Share Price

Open 23.50 Change Price %
High 24.00 1 Day -0.40 -1.69
Low 23.05 1 Week 0.50 2.20
Close 23.25 1 Month 0.00 0.00
Volume 10207 1 Year -34.35 -59.64
52 Week High 65.15
52 Week Low 19.30
PDPL Important Levels
Resistance 2 24.13
Resistance 1 23.77
Pivot 23.43
Support 1 22.73
Support 2 22.37
NSE INDIA Most Active Stocks
SUZLON 15.60 2.63%
ESL 5.05 8.60%
ESL 5.05 8.60%
ESL 5.05 8.60%
ESL 5.05 8.60%
NHPC 29.95 -0.83%
DLF 131.65 1.39%
PNB 130.25 1.20%
AXISBANK 487.20 2.08%
HDIL 63.50 -1.70%
More..
NSE INDIA Top Gainers Stocks
KSERASERA 0.20 33.33%
FACT 33.70 19.93%
PALREDTEC 132.00 18.17%
FCSSOFT 0.35 16.67%
JAIHINDPRO 6.95 13.93%
WEIZFOREX 213.30 12.98%
DATAMATICS 153.55 11.19%
NAHARPOLY 66.60 11.00%
MVL 0.55 10.00%
MVL 0.55 10.00%
More..
NSE INDIA Top Losers Stocks
PRADIP 1.70 -12.82%
SRGINFOTEC 0.35 -12.50%
NICCO 0.45 -10.00%
SPMLINFRA 55.30 -9.42%
ZENITHBIR 0.75 -6.25%
TECHIN 3.85 -6.10%
VISUINTL 0.80 -5.88%
INFOMEDIA 5.75 -5.74%
PENPEBS 143.55 -5.56%
PNEUMATIC 845.75 -5.50%
More..

Parenteral Drugs (India) Limited (NSE: PDPL)

PDPL Technical Analysis 2
As on 17th Jan 2017 PDPL Share Price closed @ 23.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 32.01 & Buy for SHORT-TERM with Stoploss of 22.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
PDPL Target for January
1st Target up-side 26.94
2nd Target up-side 30.26
3rd Target up-side 33.59
1st Target down-side 17.46
2nd Target down-side 14.14
3rd Target down-side 10.81
PDPL Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
PDPL Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
PDPL Address
PDPL
N/A
Interactive Technical Analysis Chart Parenteral Drugs (India) Limited ( PDPL NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Parenteral Drugs (India) Limited
PDPL Business Profile
Parenteral Drug is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 112.11 crore.The company has reported a consolidated sales of Rs 75.90 crore and a Net Loss of Rs 13.73 crore for the quarter ended Sep 2013.The company management includes Manoharlal Gupta - Chairman, Vinod Kumar Gupta - Managing Director, Govind Das Garg - Whole Time Director, Anil Mittal - Wholetime Director & CEO, Satish Chandra Consul - Independent Director, Dharam Pal Khanna - Independent Director, Dilip Kumar Panchaity - Independent Director, Dilip Kumar Sinha - Independent Director, Satish Moreshwar Joshi - Nominee Director. It is listed on the BSE with a BSE Code of 524689 and the NSE with an NSE Code of PDPL.Its Registered office is at 340, Laxmi Plaza, Laxmi Industrial Estate,,New Link Road, Mumbai,Maharashtra - 400053.Their Registrars are Link Intime India Pvt. Ltd.